Isbn: 9780309083522 - developing new contraceptives: obstacles and opportunities (19 resultados)

Condición: As New. Unread book in perfect condition.

Condición: New.

Paperback. Condición: new. Paperback. There are numerous reasons to hasten the introduction of new and improved contraceptives--from health concerns about the pill to the continuing medical liability crisis. Yet, U.S. organizations are far from taking a leadership position in funding, researching, and introducing new contraceptives--in fact, the United States lags behind Europe and even some developing countries in this field. Why is research and development of contraceptives stagnating? What must the nation do to energize this critical arena? This book presents an overall examination of contraceptive development in the United States--covering research, funding, regulation, product liability, and the effect of public opinion. The distinguished authoring committee presents a blueprint for substantial change, with specific policy recommendations that promise to gain the attention of specialists, the media, and the American public.The highly readable and well-organized volume will quickly become basic reading for legislators, government agencies, the pharmaceutical industry, private organizations, legal professionals, and researchers--everyone concerned about family planning, reproductive health, and the impact of the liability and regulatory systems on scientific innovations. Presents an examination of contraceptive development in the United States, covering research, funding, regulation, product liability, and the effect of public opinion. This book provides a blueprint for substantial change, with specific policy recommendations that promise to gain the attention of specialists, the media, and the American public. Shipping may be from multiple locations in the US or from the UK, depending on stock availability. …

Condición: As New. Unread book in perfect condition.

Condición: New.

Paperback. Condición: Brand New. 212 pages. 9.00x6.00x9.00 inches. In Stock.

Paperback / softback. Condición: New. New copy - Usually dispatched within 4 working days.

Paperback. Condición: new. Paperback. There are numerous reasons to hasten the introduction of new and improved contraceptives--from health concerns about the pill to the continuing medical liability crisis. Yet, U.S. organizations are far from taking a leadership position in funding, researching, and introducing new contraceptives--in fact, the United States lags behind Europe and even some developing countries in this field. Why is research and development of contraceptives stagnating? What must the nation do to energize this critical arena? This book presents an overall examination of contraceptive development in the United States--covering research, funding, regulation, product liability, and the effect of public opinion. The distinguished authoring committee presents a blueprint for substantial change, with specific policy recommendations that promise to gain the attention of specialists, the media, and the American public.The highly readable and well-organized volume will quickly become basic reading for legislators, government agencies, the pharmaceutical industry, private organizations, legal professionals, and researchers--everyone concerned about family planning, reproductive health, and the impact of the liability and regulatory systems on scientific innovations. Presents an examination of contraceptive development in the United States, covering research, funding, regulation, product liability, and the effect of public opinion. This book provides a blueprint for substantial change, with specific policy recommendations that promise to gain the attention of specialists, the media, and the American public. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability. …

PAP. Condición: New. New Book. Shipped from UK. Established seller since 2000.

PAP. Condición: New. New Book. Shipped from UK. Established seller since 2000.

Condición: New. In English.

Condición: NEW.

Condición: New. Presents an examination of contraceptive development in the United States, covering research, funding, regulation, product liability, and the effect of public opinion. This book provides a blueprint for substantial change, with specific policy recommendations that promise to gain the attention of specialists, the media, and the American public. Num Pages: 212 pages. BIC Classification: KNDP; MBNH4. Category: (P) Professional & Vocational. Dimension: 229 x 152. . . 1990. Revised ed. paperback. . . . .…

Paperback. Condición: New. There are numerous reasons to hasten the introduction of new and improved contraceptives--from health concerns about the pill to the continuing medical liability crisis. Yet, U.S. organizations are far from taking a leadership position in funding, researching, and introducing new contraceptives--in fact, the United States lags behind Europe and even some developing countries in this field. Why is research and development of contraceptives stagnating? What must the nation do to energize this critical arena? This book presents an overall examination of contraceptive development in the United States--covering research, funding, regulation, product liability, and the effect of public opinion. The distinguished authoring committee presents a blueprint for substantial change, with specific policy recommendations that promise to gain the attention of specialists, the media, and the American public.The highly readable and well-organized volume will quickly become basic reading for legislators, government agencies, the pharmaceutical industry, private organizations, legal professionals, and researchers--everyone concerned about family planning, reproductive health, and the impact of the liability and regulatory systems on scientific innovations.…

Condición: New. Presents an examination of contraceptive development in the United States, covering research, funding, regulation, product liability, and the effect of public opinion. This book provides a blueprint for substantial change, with specific policy recommendatio.

Condición: New. Presents an examination of contraceptive development in the United States, covering research, funding, regulation, product liability, and the effect of public opinion. This book provides a blueprint for substantial change, with specific policy recommendations that promise to gain the attention of specialists, the media, and the American public. Num Pages: 212 pages. BIC Classification: KNDP; MBNH4. Category: (P) Professional & Vocational. Dimension: 229 x 152. . . 1990. Revised ed. paperback. . . . . Books ship from the US and Ireland.…

Taschenbuch. Condición: Neu. Developing New Contraceptives | Obstacles and Opportunities | Commission on Behavioral and Social Sciences and Education (u. a.) | Taschenbuch | Kartoniert / Broschiert | Englisch | 1990 | National Academies Press | EAN 9780309083522 | Verantwortliche Person für die EU: Libri GmbH, Europaallee 1, 36244 Bad Hersfeld, gpsr[at]libri[dot]de | Anbieter: preigu. …

Paperback. Condición: New. There are numerous reasons to hasten the introduction of new and improved contraceptives--from health concerns about the pill to the continuing medical liability crisis. Yet, U.S. organizations are far from taking a leadership position in funding, researching, and introducing new contraceptives--in fact, the United States lags behind Europe and even some developing countries in this field. Why is research and development of contraceptives stagnating? What must the nation do to energize this critical arena? This book presents an overall examination of contraceptive development in the United States--covering research, funding, regulation, product liability, and the effect of public opinion. The distinguished authoring committee presents a blueprint for substantial change, with specific policy recommendations that promise to gain the attention of specialists, the media, and the American public.The highly readable and well-organized volume will quickly become basic reading for legislators, government agencies, the pharmaceutical industry, private organizations, legal professionals, and researchers--everyone concerned about family planning, reproductive health, and the impact of the liability and regulatory systems on scientific innovations.…

Taschenbuch. Condición: Neu. Neuware - There are numerous reasons to hasten the introduction of new and improved contraceptives--from health concerns about the pill to the continuing medical liability crisis. Yet, U.S. organizations are far from taking a leadership position in funding, researching, and introducing new contraceptives--in fact, the United States lags behind Europe and even some developing countries in this field. Why is research and development of contraceptives stagnating What must the nation do to energize this critical arena This book presents an overall examination of contraceptive development in the United States--covering research, funding, regulation, product liability, and the effect of public opinion. The distinguished authoring committee presents a blueprint for substantial change, with specific policy recommendations that promise to gain the attention of specialists, the media, and the American public. The highly readable and well-organized volume will quickly become basic reading for legislators, government agencies, the pharmaceutical industry, private organizations, legal professionals, and researchers--everyone concerned about family planning, reproductive health, and the impact of the liability and regulatory systems on scientific innovations. …